AWARD
A -- DAS181: A Broad-Spectrum Antiviral Therapeutic for Treatment of Influenza A & B
- Notice Date
- 9/26/2012
- Notice Type
- Award Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 330 Independence Ave. SW, G640, Washington, District of Columbia, 20201, United States
- ZIP Code
- 20201
- Solicitation Number
- BAA-11-100-SOL-00021
- Point of Contact
- Brooke Bernold, Phone: 2022600690, Pedro Godinez, Phone: 202-260-8500
- E-Mail Address
-
brooke.bernold@hhs.gov, Pedro.Godinez@hhs.gov
(brooke.bernold@hhs.gov, Pedro.Godinez@hhs.gov)
- Small Business Set-Aside
- N/A
- Award Number
- HHSO100201200011C
- Award Date
- 9/26/2012
- Awardee
- NexBio, Incorporated , 10665 Sorrento Valley Road, San Diego, California 92121, United States
- Award Amount
- $26,504,502.00
- Description
- This announcement is for the award of a Cost Plus Fixed Fee (CPFF) type Research and Development contract to NexBio, Incorporated for the development DAS181, A Broad-Spectrum Antiviral Therapeutic for Treatment of Influenza A and B Virus Infections under the procedures of the subject Broad Agency Announcement (BAA). The major goal of this contract is to successfully complete a Phase 2B clinical trial which will advance DAS181 towards NDA filing and approval for treatment of influenza.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/Awards/HHSO100201200011C.html)
- Record
- SN02899530-W 20120928/120926235759-8736a05deadd7f9a2ccec75cc49c94cf (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |